Cox, Wardlaw and Webster, J. Chem. Soc., 775 (1936); Mann, Purdie and Wells, J. Chem. Soc., 1503 (1936). Pope and Peachey, Proc. Chem. Soc., 42, 116 (1900).

Regulatory authorities in the US are investigating a possible link between the new Pfizer/BioNTech bivalent COVID-19 booster vaccine and strokes in people aged 65 or over, but still recommend the ...

Moderna has reported preliminary clinical results with a bivalent version of its COVID-19 vaccine that combines its original version with another targeting the Beta variant, and seems to offer ...

Georg Winter at the Research Center for Molecular Medicine (CEMM) of the Austrian Academy of Sciences in Vienna, have defined a new class of so-called "intramolecular bivalent glue," which bind ...

"Bivalent mRNA booster vaccination in adults aged 65 years or older is an effective and essential tool to reduce their risk of hospitalisation and death due to Covid-19.